Health and Safety at ATS 2022

HomeAttendees ▶ Health and Safety at ATS 2022

Posted on October 6, 2021

The American Thoracic Society believes that everyone deserves to be respected and safe whenever participating in ATS activities. This includes the International Conference, where physicians, nurses, researchers, patients, and family members from throughout the world, as well as vendors and exhibitors of relevant products and services, are present. As such, the ATS will adhere to all requirements specified by the State of California, the City of San Francisco, and facility best practices to prevent the spread of COVID-19 during ATS 2022 in San Francisco.

COVID protocols in San Francisco

The ATS will require all attendees, including exhibitors, vendors and staff, to show proof of being fully vaccinated* against COVID‐19 before being allowed to enter any conference facilities. This includes the Moscone Conference Center, headquarter hotels, and other facilities at which official ATS conference events will take place.

In the near future, we will provide additional information explaining how people can comply with these requirements.

As the meeting approaches, we will continually review the latest guidelines from the Centers for Disease Control and Prevention and World Health Organization, as well as industry best practices. We will update our policies accordingly as they relate to local conditions and risk factors and will continue to comply with all applicable laws and regulations.

This policy is subject to change. Please check back with us regularly.

* Fully vaccinated means two weeks after the second dose in a two dose series, such as the Pfizer and Moderna vaccines, or two weeks after a single-dose vaccine, such as Johnson & Johnson's Janssen vaccine. Accepted vaccinations include those authorized for emergency use by the U.S. Food and Drug Administration (i.e., Pfizer-BioNTech, Moderna, and Johnson and Johnson (J&J/Janssen COVID-19 vaccines), and COVID-19 vaccines authorized for emergency use by the World Health Organization (i.e., AstraZeneca/Oxford, Covishield, Sinopharm, and Sinovac).